199 related articles for article (PubMed ID: 20667001)
21. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis.
Campanha NH; Neppelenbroek KH; Spolidorio DM; Spolidorio LC; Pavarina AC
Oral Dis; 2005 Nov; 11(6):392-8. PubMed ID: 16269032
[TBL] [Abstract][Full Text] [Related]
23. Importance of Candida species other than Candida albicans as opportunistic pathogens.
Coleman DC; Rinaldi MG; Haynes KA; Rex JH; Summerbell RC; Anaissie EJ; Li A; Sullivan DJ
Med Mycol; 1998; 36 Suppl 1():156-65. PubMed ID: 9988504
[TBL] [Abstract][Full Text] [Related]
24. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia.
Rodríguez-Leguizamón G; Fiori A; López LF; Gómez BL; Parra-Giraldo CM; Gómez-López A; Suárez CF; Ceballos A; Van Dijck P; Patarroyo MA
BMC Microbiol; 2015 Oct; 15():199. PubMed ID: 26438104
[TBL] [Abstract][Full Text] [Related]
25. [Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].
Toraman ZA; Bulut Y; Yilmaz M; Ozdarendeli A
Mikrobiyol Bul; 2005 Apr; 39(2):199-204. PubMed ID: 16128031
[TBL] [Abstract][Full Text] [Related]
26. Candida dubliniensis: ten years on.
Sullivan DJ; Moran GP; Coleman DC
FEMS Microbiol Lett; 2005 Dec; 253(1):9-17. PubMed ID: 16213674
[TBL] [Abstract][Full Text] [Related]
27. Candida dubliniensis: first identification in Sfax Hospital, Tunisia.
Khlif M; Sellami H; Sellami A; Chelly H; Makni F; Bouaziz M; Ayadi A
Mycoses; 2009 Mar; 52(2):171-5. PubMed ID: 18522698
[TBL] [Abstract][Full Text] [Related]
28. [Candida dubliniensis: Identification methods and epidemiologic implication].
Khlif M; Sellami A; Sellami H; Makni F; Ayadi A
Pathol Biol (Paris); 2011 Jun; 59(3):166-72. PubMed ID: 19046828
[TBL] [Abstract][Full Text] [Related]
29. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis.
Yazdanparast SA; Khodavaisy S; Fakhim H; Shokohi T; Haghani I; Nabili M; Gholami H; Ahmadi I; Badali H
Mycopathologia; 2015 Dec; 180(5-6):317-23. PubMed ID: 26183965
[TBL] [Abstract][Full Text] [Related]
30. Comparison of phenotypic methods for the identification of Candida dubliniensis.
Pasligh J; Radecke C; Fleischhacker M; Ruhnke M
J Microbiol Immunol Infect; 2010 Apr; 43(2):147-54. PubMed ID: 20457432
[TBL] [Abstract][Full Text] [Related]
31. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.
Jacobsen MD; Boekhout T; Odds FC
FEMS Yeast Res; 2008 Aug; 8(5):764-70. PubMed ID: 18547330
[TBL] [Abstract][Full Text] [Related]
32. Initial Candida dubliniensis isolate in Candida spp. positive haemocultures in Turkey between 2001 and 2004.
Tekeli A; Akan OA; Koyuncu E; Dolapci I; Uysal S
Mycoses; 2006 Jan; 49(1):60-4. PubMed ID: 16367821
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
Mokaddas E; Khan ZU; Ahmad S
Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method.
Mirhendi H; Makimura K; Zomorodian K; Maeda N; Ohshima T; Yamaguchi H
Jpn J Infect Dis; 2005 Aug; 58(4):235-7. PubMed ID: 16116258
[TBL] [Abstract][Full Text] [Related]
35. New PCR primer pairs specific for Candida dubliniensis and detection of the fungi from the Candida albicans clinical isolates in Japan.
Tamura M; Watanabe K; Imai T; Mikami Y; Nishimura K
Clin Lab; 2000; 46(1-2):33-40. PubMed ID: 10745979
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom.
Borman AM; Szekely A; Linton CJ; Palmer MD; Brown P; Johnson EM
J Clin Microbiol; 2013 Mar; 51(3):967-72. PubMed ID: 23303503
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of the NRG1 repressor controls species-specific regulation of chlamydospore development in Candida albicans and Candida dubliniensis.
Staib P; Morschhäuser J
Mol Microbiol; 2005 Jan; 55(2):637-52. PubMed ID: 15659176
[TBL] [Abstract][Full Text] [Related]
38. [An update on Candida dubliniensis].
Paugam A; Baixench MT; Viguié C
Med Mal Infect; 2008 Jan; 38(1):1-7. PubMed ID: 18065177
[TBL] [Abstract][Full Text] [Related]
39. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
[TBL] [Abstract][Full Text] [Related]
40. Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient.
Mubareka S; Vinh DC; Sanche SE
Transpl Infect Dis; 2005; 7(3-4):146-9. PubMed ID: 16390404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
